Antiretroviral Therapy Journal Articles

• COVID-19 Pandemic Impacts on ART Prescriptions in the U.S. The COVID-19 pandemic has resulted in major disruptions in many areas of health care. How has it impacted HIV care and ART use?
  AIDS, September 27, 2022
• Early HIV Treatment and Survival Over Six Years Does immediate ART initiation provide long-term survival benefits? An analysis of mortality rates among trial participants provides insight.
  HIV Medicine, September 21, 2022
• Switching to B/F/TAF in Suppressed HIV With M184V/I Is switching to this treatment regimen an effective means of maintaining viral suppression among people with HIV with the M184V/I resistance mutation?
  AIDS, September 20, 2022
• NAFLD and Liver Fibrosis Increase Cardiovascular Risk in HIV Are people living with HIV with NAFLD and/or liver fibrosis at a greater risk for cardiovascular disease? A new study explores the potential link.
  HIV Medicine, September 14, 2022
• Hospitalization and ED Visits for COVID-19 After Paxlovid How often have paxlovid-treated COVID-19 patients presented to the hospital or ED for symptom recurrence?
  Morbidity & Mortality Weekly Report, September 14, 2022
• Hypertension in HIV Treated With INSTIs vs Other Regimens How common is hypertension among HIV patients receiving INSTI-based ART compared with those treated with other ART regimens?
  HIV Medicine, September 07, 2022
• TDF Therapy to Prevent HBV Vertical Transmission This study investigated the efficacy and safety of tenofovir disoproxil fumarate administration to prevent HBV mother-to-child transmission
  Liver International, September 06, 2022
• ART Impact on Pregnancy and Infant Outcomes in HIV/HBV Women Are certain ART regimens associated with a greater risk of adverse outcomes among pregnant women with HIV/HBV? Find out what there is to know.
  JAIDS: Journal of Acquired Immune Deficiency Syndromes, September 05, 2022
• A Demedicalized Sexual Health Clinic PrEP Model Could the implementation of this program help improve HIV PrEP uptake and retention among high-risk groups?
  JAIDS: Journal of Acquired Immune Deficiency Syndromes, August 31, 2022
• HIV Viremia and Virological Failure in the Era of INSTIs Has the use of INSTI-based ART regimens impacted the rates of low-level viremia and virological failure among people with HIV?
  HIV Medicine, August 31, 2022
• Adverse Perinatal Outcomes Linked to HAART and Monotherapy Is there a higher risk for adverse perinatal outcomes among women with HIV receiving HAART or monotherapy during pregnancy?
  AIDS, August 22, 2022
• HCV Micro-Elimination Within a Clinic for People With HIV This article highlights the challenges that remain in reaching HCV micro-elimination among people living with HIV.
  HIV Medicine, August 17, 2022
• Efficacy and Safety of Alfosbuvir Plus Daclatasvir in HCV This study investigated the efficacy and safety of oral alfosbuvir 400, 600 or 800 mg daily combined with 60 mg daily of daclatasvir for the treatment of HCV infection.
  Journal of Viral Hepatitis, August 09, 2022
• Effectiveness of INSTIs in Treatment-Experienced HIV How effective are INSTI-based regimens in pre-treated HIV patients?
  HIV Medicine, August 03, 2022
• Identifiying HCV Patients Who May Be Cured in 4 Weeks Are soluble inflammatory mediators useful as biomarkers for prediction of a successful ultrashort antiviral treatment regimen for chronic HCV?
  Journal of Viral Hepatitis, July 26, 2022
• Clinical Decision Support Systems to Guide HIV Testing The implementation of clinical decision support systems helps healthcare providers make decisions on HIV testing and in turn, improves testing rates.
  AIDS, July 20, 2022
• Factors Associated With COVID-19 Severity in People With HIV Learn more about the risk factors associated with COVID-19 severity among people living with HIV.
  JAIDS: Journal of Acquired Immune Deficiency Syndromes, July 20, 2022
• Hospitalized AKI Among People Living With HIV on ART How common is acute kidney injury among people with HIV, and what are the risk factors? A new study looks at the incidence rates of these events in recent years.
  HIV Medicine, July 18, 2022
• TAF With Boosted PI in Pregnant and Postpartum Women Do the results from this study support the use of this combination HIV treatment during the pregnancy and postpartum period?
  JAIDS: Journal of Acquired Immune Deficiency Syndromes, July 12, 2022
• The HIV360 Set of Outcome Measures for Adults With HIV This article describes the development of a standardized, consensus-based set of outcome measures for adults living with HIV.
  HIV Medicine, July 11, 2022